Protective Effect of Interferon-based Antiviral Therapy on Risk of Bipolar Disorder in Patients with Hepatitis C Virus Infection: A Nationwide Longitudinal Study

10.4103/TPSY.TPSY_37_22

Mu-Hong Chen；Shih-Jen Tsai；Tzeng-Ji Chen

depression ； inflammation ； temporal association ； the Taiwan National Health Insurance Research Database

台灣精神醫學

36卷4期（2022 / 12 / 01）

182 - 187

英文

Background: A recent study has shown the beneficial effects of interferon (IFN)-based antiviral therapy (AVT) in reducing the risk of newly diagnosed depression among patients with hepatitis C virus (HCV) infection. But whether IFN-based AVT reduces the risk of bipolar disorder remains unknown. Methods: This is a retrospective study based on the Taiwan National Health Insurance Research Database. From enrollment to the end of 2013, 24,240 patients with HCV infection (4473 treated with IFN-based AVT and 19,767 without such treatment) as well as 96,960 age- and sex-matched controls were included in this study. Time-dependent Cox regression models were used to study the differences in risk of newly-diagnosed bipolar disorder between patients being treated with and without IFN-based AVT and the control participants. Results: Patients with HCV infection who had not yet received IFN-based AVT (hazard ratio = 4.86, 95% confidence interval = 1.87-12.66, p = 0.001), but not those who were receiving IFN-based AVT (1.69, 0.94 - 30.50, nonsignificance) and those who completed the IFN-based AVT (1.77, 0.69 - 4.54, nonsignificance), were significantly more to be diagnosed with bipolar disorder compared with the control group. Conclusion: Our study supports the temporal association between HCV infection and subsequent bipolar disorder, further suggesting that the optimal AVT to eradicate HCV may be associated with a reduced risk of incident bipolar disorder later in life.

1. Alvarado Esquivel, C,Elewaut, A,Philippé, J(2002).Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.Rev Invest Clin,54,41-50.
2. Bai, YM,Su, TP,Li, CT(2015).Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.Bipolar Disord,17,269-277.
3. Bauer-Staeb, C,Jörgensen, L,Lewis, G(2017).Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: A total population study of Sweden.Lancet Psychiatry,4,685-693.
4. Bladowska, J,Pawłowski, T,Fleischer-Stępniewska, K(2019).Interferonfree therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C.Viral Hepat,26,635-643.
5. Bladowska, J,Zimny, A,Knysz, B(2013).Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: A pilot study.J Hepatol,59,651-657.
6. Butt, AA,Evans, R,Skanderson, M(2006).Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis.J Hepatol,44,864-868.
7. Cattarinussi, G,Di Giorgio, A,Wolf, RC(2019).Neural signatures of the risk for bipolar disorder: a meta-analysis of structural and functional neuroimaging studies.Bipolar Disord,21,215-227.
8. Charlson, ME,Pompei, P,Ales, KL(1987).A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis,40,373-383.
9. Chen, MH,Hsu, JW,Huang, KL(2018).Sexually transmitted infection among adolescents and young adults with attention-deficit/hyperactivity disorder: A nationwide longitudinal study.J Am Acad Child Adolesc Psychiatry,57,48-53.
10. Chen, MH,Lan, WH,Hsu, JW(2016).Risk of developing Type 2 diabetes in adolescents and young adults with autism spectrum disorder: A nationwide longitudinal study.Diabetes Care,39,788-793.
11. Chen, MH,Pan, TL,Li, CT(2015).Risk of stroke among patients with post-traumatic stress disorder: nationwide longitudinal study.Br J Psychiatry,206,302-307.
12. Cheng, CM,Chang, WH,Chen, MH(2018).Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study.Mol Psychiatry,23,1756-1763.
13. Chiu, WC,Lu, ML,Chang, CC(2020).Mental disorders and interferon nontreatment in hepatitis C virus infection-a population based cohort study.Psychiatry Investig,17,268-274.
14. Choi, HY,Mai, TH,Kim, KA(2020).Association between viral hepatitis infection and Parkinson’s disease: a population-based prospective study.J Viral Hepat,27,1171-1178.
15. Chong, LW,Hsu, CC,Lee, CY(2018).Association of viral hepatitis and bipolar disorder: a nationwide population-based study.J Transl Med,16,173.
16. Hjerrild, S,Renvillard, SG,Leutscher, P(2016).Reduced cerebral cortical thickness in Non-cirrhotic patients with hepatitis C.Metab Brain Dis,31,311-319.
17. Hsu, YC,Ho, HJ,Huang, YT(2015).Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.Gut,64,495-503.
18. Huang, CF,Hsieh, MY,Yang, JF(2010).Serum HS-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.Hepatol Int,4,621-627.
19. Hughes, E,Bassi, S,Gilbody, S(2016).Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis.Lancet Psychiatry,3,40-48.
20. Kuhn, T,Sayegh, P,Jones, JD(2017).Improvements in brain and behavior following eradication of hepatitis C.J Neurovirol,23,593-602.
21. Li, HC,Lo, SY(2015).Hepatitis C virus: Virology, diagnosis and treatment.World J Hepatol,7,1377-1389.
22. Liao, CC,Su, TC,Sung, FC(2012).Does hepatitis C virus infection increase risk for stroke? a population-based cohort study.PLoS One,7,e31527.
23. Lin, WY,Lin, MS,Weng, YH(2019).Association of antiviral therapy with risk of Parkinson disease in patients with chronic hepatitis C virus infection.JAMA Neurol,76,1019-1027.
24. Liu, CY,Hung, YT,Chuang, YL(2006).Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey.J Health Manage,4,1-22.
25. Lu, DY,Leung, YM,Su, KP(2013).Interferon-α induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: Implications of cellular mechanism of IFN-α-induced depression.Int J Neuropsychopharmacol,16,433-444.
26. Lu, X,Zhong, Y,Ma, Z(2019).Structural imaging biomarkers for bipolar disorder: meta-analyses of whole-brain voxel-based morphometry studies.Depress Anxiety,36,353-364.
27. Manns, MP,Buti, M,Gane, E(2017).Hepatitis C virus infection.Nat Rev Dis Primers,3,17006.
28. McCready, H,Kohno, M,Kolessar, M(2018).Functional MRI and delay discounting in patients infected with hepatitis C.J Neurovirol,24,738-751.
29. Omata, M,Kanda, T,Yu, ML(2012).APASL consensus statements and management algorithms for hepatitis C virus infection.Hepatol Int,6,409-435.
30. Rosenberg, SD,Goodman, LA,Osher, FC(2001).Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.Am J Public Health,91,31-37.
31. Su, KP(2015).Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression.Biomedicine,5,21.
32. Su, KP,Lai, HC,Peng, CY(2019).Interferon-alpha-induced depression: Comparisons between early and late-onset subgroups and with patients with major depressive disorder.Brain Behav Immun,80,512-518.
33. Sun, CF,Chiu, WC,Chen, PC(2020).Depression-free after interferon-α exposure indicates less incidence of depressive disorder: a longitudinal study in Taiwan.Brain Behav Immun,88,125-131.
34. Torre, F,Rossol, S,Pelli, N(2004).Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: Comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.Clin Exp Immunol,136,507-512.
35. Tsao, YC,Chen, JY,Yeh, WC(2017).Association between visceral obesity and hepatitis C infection stratified by gender: a cross-sectional study in Taiwan.BMJ Open,7,e017117.
36. White, DL,Ratziu, V,El-Serag, HB(2008).Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis.J Hepatol,49,831-844.